Cephalon Showcasing Treanda Use For Refractory Indolent NHL At ASH

Cephalon's oncology drug Treanda is getting attention at the 2008 American Society of Hematology annual meeting, where the company is starting to showcase its use in the newest indication - refractory indolent non-Hodgkins lymphoma